XML 22 R7.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 28, 2025
Dec. 29, 2024
Dec. 31, 2023
Cash flows from operating activities:      
Net loss $ (134,065) $ (90,373) $ (113,384)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:      
Depreciation and amortization 71,537 67,346 59,491
Amortization of lease acquisition costs 92 93 92
Amortization of loan origination fees 0 71 55
Amortization of cloud computing arrangements 1,009 914 880
Operating lease cost 35,316 31,475 29,113
Loss on disposal of property and equipment 1,431 255 687
Stock-based compensation 36,475 39,024 49,532
Impairment and closure costs 11,556 1,835 90
Non-cash restructuring charges 861 701 5,281
Deferred income tax (benefit) expense (89) (1,412) 358
Change in fair value of contingent consideration liability (974) 6,624 3,475
Changes in operating assets and liabilities:      
Accounts receivable (132) (1,532) (258)
Inventory (397) 82 (686)
Prepaid expenses and other current assets 4,338 (22) (3,789)
Operating lease liabilities (40,523) (18,318) (22,290)
Accounts payable 1,186 759 9,871
Accrued payroll and benefits (6,573) 1,585 6,551
Accrued expenses and other current liabilities 5,810 3,313 1,163
Gift card and loyalty liability 2,764 1,616 781
Contingent consideration liability (2,291) 0 0
Other non-current liabilities (27) (646) (533)
Net cash (used in) provided by operating activities (12,696) 43,390 26,480
Cash flows from investing activities:      
Purchase of property and equipment (106,492) (84,457) (89,672)
Purchase of intangible assets (7,813) (7,741) (6,115)
Security and landlord deposits 54 (13) 122
Net cash used in investing activities (114,251) (92,211) (95,665)
Cash flows from financing activities:      
Proceeds from stock option exercise 3,120 12,765 5,388
Payment of contingent consideration 0 (3,868) (10,421)
Payment associated to shares repurchased for tax withholding (259) (2) (166)
Net cash provided by (used in) financing activities 2,861 8,895 (5,199)
Net decrease in cash and cash equivalents and restricted cash (124,086) (39,926) (74,384)
Cash and cash equivalents and restricted cash—beginning of year 217,429 257,355 331,739
Cash and cash equivalents and restricted cash—end of year 93,343 217,429 257,355
Supplemental disclosure of cash flow:      
Cash paid for interest 19 184 50
Non-cash investing and financing activities:      
Purchase of property and equipment accrued in accounts payable and accrued expenses 11,190 9,791 6,824
Stock Issued $ 0 $ 2,132 $ 0